Asset Planning Services (Pennsylvania)’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
– Sell
-100
Closed – – 289
2018
Q1
$0 Hold
100
– – ﹤0.01% 297
2017
Q4
$0 Hold
100
– – ﹤0.01% 321
2017
Q3
$0 Hold
100
– – ﹤0.01% 319
2017
Q2
$0 Hold
100
– – ﹤0.01% 324
2017
Q1
$0 Hold
100
– – ﹤0.01% 324
2016
Q4
$0 Hold
100
– – ﹤0.01% 293
2016
Q3
$0 Buy
+100
New +$378 ﹤0.01% 304

Other funds holding OREX

Asset Planning Services (Pennsylvania)'s OREX Position: Q2 2018 in Review

Asset Planning Services (Pennsylvania) sold out of Orexigen Therapeutics, Inc. (OREX) in Q2 2018, closing a stake of 100 shares.

Asset Planning Services (Pennsylvania) first reported a position in OREX in Q3 2016 and held it in 7 quarters. The position peaked at $0 in Q1 2018. 4 funds tracked by Wall St. Rank hold OREX as of Q2 2018.

  • Asset Planning Services (Pennsylvania) reported no remaining Orexigen Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
  • Asset Planning Services (Pennsylvania) sold 100 Orexigen Therapeutics, Inc. shares in Q2 2018.
  • Asset Planning Services (Pennsylvania) first reported a position in Orexigen Therapeutics, Inc. in Q3 2016 and held it in 7 quarters.
  • Asset Planning Services (Pennsylvania)'s Orexigen Therapeutics, Inc. position peaked at $0 in Q1 2018.
  • 4 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q2 2018.

Based on Asset Planning Services (Pennsylvania)'s 13F filing for Q2 2018, filed 1 Aug 2018.